Oritavancin
From IDWiki
Revision as of 17:58, 11 August 2019 by Maintenance script (talk | contribs) (Imported from text file)
Oritavancin
Classification
- Semisynthetic lipoglycopeptide antibiotic with very long half-life
Indications
- MRSA skin and soft tissue infections
Dosing
- IV once a week, long-acting
Renal Dosing
- Not required